[Prevention and therapy of cardiac rhythm disorders. Experiences with a diphenylhydantoin-meprobamate preparation (Cusitan)].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000209:etiology; D005117:Cardiac Complexes, Premature / Q000188:drug therapy / Q000209:etiology; D009202:Cardiomyopathies / Q000150:complications; D003327:Coronary Disease / Q000150:complications; D004071:Digitalis Glycosides / Q000506:poisoning; D005260:Female; D006801:Humans; D008297:Male; D008620:Meprobamate / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000150:complications; D008946:Mitral Valve Stenosis / Q000150:complications; D009203:Myocardial Infarction / Q000150:complications / Q000517:prevention & control; D010672:Phenytoin / Q000008:administration & dosage / Q000627:therapeutic use*
D004071:Digitalis Glycosides; D010672:Phenytoin; D008620:Meprobamate
Zur Prophylaxe und Therapie von Herzrhythmusstörungen. Erfahrungen mit einem Diphenylhydantoin-Meprobamat-Präparat (Cusitan)